Patent ID: 9616017
Date: 2017-04-11
CPC Classifications: A61K,A61P

Claim:
1. An ophthalmic pharmaceutical product comprising: a stabilizing composition comprising a therapeutically active agent; a liquid vehicle composition; a removable barrier; wherein the removable barrier is in simultaneous contact with the stabilizing composition and the liquid composition and the removable barrier is configured to prevent contact between the stabilizing composition and the liquid vehicle composition; and wherein the product is configured to allow removal of the barrier; wherein the product is configured so that removal of the barrier allows mixing of the stabilizing composition and the vehicle composition to provide a sterile ophthalmically acceptable liquid; and wherein the ophthalmically acceptable liquid comprises a therapeutic amount of the therapeutically active agent; and wherein the therapeutically active agent is selected from the group consisting of phentolamine, cyclosporin, ketorolac, testosterone or a derivative thereof, docosehexaenoic acid, eicosapentaenoic acid, alpha-linolenic acid, or a pharmaceutically acceptable salt thereof.